Autologous stem cell transplantation with thiotepa, busulfan, and cyclophosphamide conditioning in patients with central nervous system lymphoma: a phase II study.
Saved in:
| Title: | Autologous stem cell transplantation with thiotepa, busulfan, and cyclophosphamide conditioning in patients with central nervous system lymphoma: a phase II study. |
|---|---|
| Authors: | Kim DH; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.; Department of Translational Medicine, Seoul National University College of Medicine, Seoul, Korea., Park T; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.; Department of Translational Medicine, Seoul National University College of Medicine, Seoul, Korea., Hong J; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.; Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea., Shin DY; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.; Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea., Kim I; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea., Yoon SS; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.; Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea., Byun JM; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea. jaminbyun@snu.ac.kr.; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea. jaminbyun@snu.ac.kr.; Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea. jaminbyun@snu.ac.kr., Koh Y; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea. go01@snu.ac.kr.; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea. go01@snu.ac.kr.; Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea. go01@snu.ac.kr. |
| Source: | Annals of hematology [Ann Hematol] 2025 Jul; Vol. 104 (7), pp. 3843-3854. Date of Electronic Publication: 2025 Jun 14. |
| Publication Type: | Journal Article; Clinical Trial, Phase II |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1432-0584 |
|---|---|
| DOI: | 10.1007/s00277-025-06405-y |
